Vinge has advised Ambea AB (publ) (“Ambea”) in connection with its listing on Nasdaq Stockholm. The prospectus was published on 20 March 2017 and the first day of trading on Nasdaq Stockholm was 31 March 2017. The price in the offering was SEK 75 per share, corresponding to a market value of Ambea of approximately SEK 5 billion. The offering comprised 26,565,495 shares, of which 2,666,667 shares were newly issued shares and 23,898,828 were existing shares offered by the selling shareholder ACTR Holding AB, as controlled by Actor SCA, a partnership between funds advised by Triton and KKR, respectively. The total value of the offering amounted to approximately SEK 2.3 billion assuming that the over-allotment option is fully exercised.

Ambea is present within care services and has around 14,000 employees. Ambea offers services within disabled care, individual and family care and elderly care, with a focus on residential care and own management. As of 31 December 2016, Ambea had approximately 6,200 beds and 1,300 school-/daily activity-placements in approximately 460 units across Sweden and Norway. In 2016, Ambea’s total sales amounted to approximately SEK 5.4 billion. The company was founded in 1996 and its head office is located in Solna, Sweden.

Vinge’s team primarily consisted of Charlotte Levin, Sofie Bjärtun, Sabina Börjesson, Nils Fredrik Dehlin, Fanny Petersson, Michaela Cronemyr, Samra Baytar and Linda Sengul.